Skip to main content
OpenTrials
Completed

NCT Number: NCT04848168

Comparison of PRISM III, PIM2 and PELOD Scoring Systems

PRISMIII(Pediatric Risk of Mortality III), PIM2(Pediatric Index of Mortality 2) and PELOD(Pediatric Logistic Organ Dysfunction) are frequently used for predicting mortality and morbidity in general pediatric ICUs(Intensive Care Units). However, the effectiveness of these scoring sistems in a specific group patients undergoing congenital heart surgery(CHS) is unknown. In this study, the investigators aimed primarily to evaluate the success of these scoring systems in predicting mortality and morbiditiy in this specific group and to compare the scoring systems with eachother, and secondly to evaluate the relationship of these systems with the STAT(STS-EACTS CHS Mortality Score) category

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Congenital Heart Disease Cardiovascular Abnormalities Cardiovascular Diseases Congenital Abnormalities Congenital, Hereditary, and Neonatal Diseases and Abnormalities Heart Defects, Congenital Heart Diseases

Age range

1 day–18 year

Sex eligibility

All sexes

Study type

Observational

Primary location

siyami ersek TRH

Istanbul, Turkey (Türkiye)

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients younger than 18 years of age who had undergone congenital heart surgery

Exclusion criteria

  • emergency operations Patients staying in intensive care unit for less than 24 hours

Treatment and study plan

Primary outcomes

  1. evaluate the success of PRISMIII, PIM2 and PELOD scoring systems in predicting mortality and morbidity

    Time frame: 3 months

    Patients younger than 18 years of age who had undergone congenital heart surgery were evaluated on the first postoperative day in the ICU and parameters were recorded. PRISMIII and PELOD scores were calculated using the most abnormal values in the first 24 hours, and PIM2 score was calculated using the data within the first hour.

  2. morbidity indicators

    Time frame: 3 months

    Morbidity indicators were determined as the length of ICU stay, total hospital stay, re-intubation, surgical revision, complications and re-admission to the ICU.

  3. clinical outcomes

    Time frame: 3 months

    Clinical outcomes were determined as 7-day mortality and 30-day mortality.

Secondary outcomes

  1. to evaluate the relationship of these systems with the STAT(STS-EACTS CHS Mortality Score) category

    Time frame: 3 months

    STAT category was determined according to the surgical procedure.

Sponsors and collaborators

Lead sponsor

Antalya Training and Research Hospital

Other Gov

Collaborators

  • Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital
  • Haydarpasa Numune Training and Research Hospital

Registry information

Official study title

Comparison Of PRISM III, PIM2 And PELOD Scoring Systems In Predicting Mortality For Patients Undergoing Congenital Cardiac Surgery In Pediatric Intensive Care Unit

Important dates

Study start
2019
Primary completion
2019
Study completion
2019
First posted
Apr 19, 2021
Registry last updated
Sep 7, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.